Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer

WHAT IS KNOWN AND OBJECTIVE: Immune checkpoint inhibitors can cause immune‐related adverse events (irAEs). Improved monitoring systems for irAEs, which include laboratory tests by a qualified multidisciplinary team, might prevent patients from irAE‐associated events. Kobe City Medical Center General...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikesue, Hiroaki, Kusuda, Kaori, Satsuma, Yukari, Nishiwaki, Fuki, Miura, Rieko, Masuda, Yoshio, Hirabatake, Masaki, Muroi, Nobuyuki, Fujimoto, Daichi, Morimoto, Takeshi, Tomii, Keisuke, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687122/
https://www.ncbi.nlm.nih.gov/pubmed/32519774
http://dx.doi.org/10.1111/jcpt.13207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687122/
https://www.ncbi.nlm.nih.gov/pubmed/32519774
http://dx.doi.org/10.1111/jcpt.13207

Ejemplares similares